via American Chemical Society
Fast, accurate and inexpensive medical tests in a doctor’s office are only possible for some conditions. To create new in-office diagnostics for additional diseases, researchers report in the journal ACS Nano a new technique that uses ultrasound to concentrate fluorescently labeled disease biomarkers otherwise impossible to detect with current equipment in an office setting.
The markers’ signal could someday be analyzed via a smartphone app.
Ultrasound is a safe, noninvasive, inexpensive and portable technique best known for monitoring pregnancies. But these high-frequency acoustic waves can also be used to gently handle blood components, cells and protein crystals at the microscopic level. With an eye toward point-of-care diagnostic applications, Tony Huang, Zhangming Mao and colleagues wanted to harness these sound waves to help detect even smaller particles and biomarkers for diseases such as cancer that often require special laboratory equipment to detect.
The researchers developed an acoustofluidic chip that, though vibrations, can form a streaming vortex inside a tiny glass capillary tube using a minimal amount of energy. Testing showed that the vortex could force nanoparticles ranging in diameter from 80 to 500 nanometers to swirl into the center of the capillary. The nanoparticles captured biomarkers labeled with a fluorescent tag, concentrating them in the capillary to boost their signal. This increased brightness could make the signal readable with a smartphone camera.
via American Chemical Society
The Latest on: Point-of-care disease diagnostics
Abbott Continues to Expand Its Diagnostics Portfolio in 2017 - Market Realist
May 25, 2017 - In 1Q17, Abbott Laboratories' (ABT) Diagnostics segment, which is involved in the sale of devices and tests to blood banks, laboratories, alternate care testing sites, and hospitals, reported revenue of nearly $1.2 billion, a year-over-year (or YoY ...
Unmet Medical Needs in Emerging Nations to Provide Considerable Growth Opportunities for Point-of-care Diagnostics ... - Digital Journal
May 24, 2017 - The rising incidence of chronic ailments is a prime driver of the global point-of-care diagnostics market. As the need for curb prevalence of chronic diseases rise, the demand for automated diagnostics is expected to surge. The past few years have ...
How Breathtec's Breath Analyzer Could Be a Key Player in the Fight Against Zika - Equities.com
May 24, 2017 - “So, for example, a clinician can make a decision at the point-of-care during the office visit as opposed to having to wait the five days for laboratory results, which is currently what's happening. This will reduce the time and cost of ... infections ...
Top 100 Developers of In-Vitro Diagnostics Tests for Infectious Diseases Market Sales, Revenue, Growth Rate, Trend ... - MilTech
May 24, 2017 - In July, 2016, the Swiss-based global biopharmaceutical group, Debiopharm Group™, acquired a majority holding in GenePOC, Inc., the Canadian developer of affordable, simple, and rapid point-of-care molecular diagnostic tests for infectious diseases.
Tiny ultra-sensitive, automated test could detect viruses, disease - NJ TODAY
May 22, 2017 - An innovation at Purdue University could allow highly sensitive detection of an infectious disease such as HIV or whooping cough by using a low-cost, automated, point-of-care test similar in packaging to a pregnancy test. The paper-based test could ...
ASU engineer working to develop disposable point-of-care sensor - Arizona State University
May 18, 2017 - Associate Professor of electrical engineering Jennifer Blain Christen holds an early prototype of a point-of-care diagnostic tool, which samples biomarkers in sweat to provide an immediate look into a patient's health. Photo by Pete Zrioka/ASU Download ...
Global $30 Billion Point of Care Testing (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases) Market ... - PR Newswire (press release)
May 9, 2017 - The report Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022 provides a detailed analysis of the current and future market scenario of the global market with a brief ...
Global Point-of-care Infectious Disease Diagnostics Market to Witness Comprehensive Growth by 2021 - MilTech
May 9, 2017 - Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, virus, and fungi. It can be spread directly or indirectly from one person to another. Fever, muscle ache, diarrhea, and fatigue are some of the common signs and ...
Ram Group Next Generation Sensor Platform Will Bring Point-of-Care Diagnostics and Wearables to Emerging Markets ... - PR Newswire (press release)
May 5, 2017 - Low-cost, rapid diagnostics at the point-of-use represent the Holy Grail for health workers who currently must deal with the burden of follow-up to patients for treatment, days or weeks after a clinical visit requiring laboratory tests. Chronic disease ...
In-Vitro Diagnostics Tests for Cancer & Infectious Diseases 2017 By Top 200 Developers (Accugenomics, Inc., Agendia ... - Medgadget (blog)
May 3, 2017 - In July, 2016, the Swiss-based global biopharmaceutical group, Debiopharm Group™, acquired a majority holding in GenePOC, Inc., the Canadian developer of affordable, simple, and rapid point-of-care molecular diagnostic tests for infectious diseases.